1222 State Street
37 articles about BioIQ
BioIQ and DermTech Enter into an Agreement to Add Non-invasive DermTech Melanoma Test to BioIQ's Health Testing Solution Lineup
BioIQ, Inc., ("BioIQ") and DermTech, Inc. (NASDAQ: DMTK) ("DermTech"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced an agreement to bring increased patient access to precision genomics.
BioIQ and Former TRICARE Program Director, Major General Elder Granger, M.D., Discuss How Employers Can Use Military Strategies to Innovate Health and Wellness Programs
BioIQ announces the release of a new on-demand webinar.
BioIQ Announces Webinar with Cambia Health Solutions Senior Vice President of Health Care Services Dr. Marion Couch on How COVID-19 Drove Innovation in Healthcare
BioIQ announces the availability of a new on-demand episode in the company's ongoing webinar series featuring health insights from industry leaders.
Healthcare Access Advocates Randy Pate and Donato Tramuto Join BioIQ Webinar Series to Discuss Avenues to Overcome US Health Disparities
The webinars highlight ways employers, payers, and government programs can improve healthcare affordability and outcomes for underserved populations.
The collaboration brings mobile and site-based vaccination operations and population engagement expertise together to improve vaccination distribution in underserved areas.
BioIQ Announces Webinar with Dr. Darria Long Addressing Breaking Research on What it Will Take to Safely Resume In-Person Learning Nationally
BioIQ's webinar series highlights critical healthcare issues facing America's education and business leaders in 2021, from national health policy to COVID-19 testing and vaccination strategy.
The acquisition brings behavioral science, AI, and virtual care enhancements to the BioIQ digital health testing platform.
BioIQ Partners with Fulgent Genetics to Bring COVID-19 Variant Detection to COVID-19 Testing Programs
The groundbreaking viral genome sequencing and reflex testing solution identifies various COVID-19 variant strains, enabling employers, health plans, and public health agencies to optimize surveillance, treatment and vaccination protocol to mitigate spread of the virus more effectively.
BioIQ and Biomeme Announce Partnership for COVID Testing, Bringing the RT-PCR Laboratory and Gold-Standard Testing to the Worksite for Fast and Highly Sensitive Results
The partnership expands BioIQ’s fully integrated healthcare services to include Biomeme’s on-site testing platform to provide accurate, real-time RT-PCR COVID-19 test results with centralized access to test scheduling and digital program management for employers, health plans, and consumers.
BioIQ’s population health testing platform was a key solution in the pandemic for millions of Americans, including those with social determinants of health.
BioIQ announced today a partnership with world-renowned Validation Institute for first-of-its-kind medical testing validation. This partnership will validate the impact of screening and diagnostic testing, providing clarity in
BioIQ is First Georgia Company Approved as Qualified Vendor for Georgia Entertainment Investment Tax Credits
Production companies can qualify for 30 percent in tax credits using BioIQ's COVID-19 testing solution to safely bring workers back and resume filming in Georgia. [16-September-2020] ATLANTA , Sept. 16, 2020 /PRNewswire/ -- BioIQ , an aggregator of testing solutions and optimizer of lab capacity for leading employers and health plans, announces that it is the first
Ernst & Young LLP announced that Justin Bellante of BioIQ was named an Entrepreneur Of The Year® 2020 Southeast Award finalist.
The self-administered COVID-19 sample collection kit offers consumers, employers, and government agencies increased capacity for home testing with the expertise of leading genomics and sequencing experts [17-June-2020] ATLANTA , June 17, 2020 /PRNewswire/ -- BioIQ , a healthcare engagement and clinical adherence technology platform company, and Phosphorus , a leadin
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 17, 2020.
BioIQ Launches First Home Test Combining COVID-19, Flu A / Flu B, and 21 Test Respiratory Panel from a Single Sample with P23 Labs
BioIQ , a healthcare engagement and clinical adherence technology platform company, announced today availability of the first home test for COVID-19 that combines COVID-19, Flu A / Flu B, and a 21 Test Respiratory Pa
BioIQ Expands Return-to-Office Support Ecosystem to Help Employers Navigate COVID-19 Testing, Legal, and Workspace Considerations
The screening and workforce reentry solution includes clinically overseen COVID-19 diagnostic and antibody testing; a population analytics, engagement, and monitoring technology platform; and a comprehensive return-to-work action plan. [05-June-2020] ATLANTA , June 5, 2020 /PRNewswire/ -- BioIQ , a healthcare engagement and clinical adherence technology platform comp
The self-administered COVID-19 sample collection kit integrates comprehensive telehealth support with the ease and convenience of at-home saliva collection.
The employee analytics, engagement, monitoring and testing solution is designed to protect workers and foster confidence as employers lay out plans for workforce re-entry.
Antibody testing is anticipated to play a critical role in getting people back to work and revitalizing the economy.